At close: January 8 at 4:00:00 PM EST
After hours: 7:59:53 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-3,826.4940
-3,224.4980
-3,497.6220
-2,278.0160
-1,156.9960
Investing Cash Flow
5,440.3400
-4,147.1070
86.7070
7,192.5260
39.0000
Financing Cash Flow
3,047.2050
-471.1210
4,940.9480
3,794.1020
2,134.6330
End Cash Position
4,860.8900
3,524.3080
11,367.0340
9,837.0010
1,128.3890
Income Tax Paid Supplemental Data
--
--
25.1590
--
--
Interest Paid Supplemental Data
5.0830
4.8690
2.1990
--
0.2240
Issuance of Capital Stock
3,414.7380
--
4,940.9480
3,794.1020
2,115.7330
Issuance of Debt
--
--
--
--
53.9000
Repayment of Debt
--
--
--
--
-35.0000
Repurchase of Capital Stock
-367.5360
-471.1210
--
--
--
Free Cash Flow
-3,826.4940
-3,224.4980
-3,497.6220
-2,278.0160
-1,156.9960
12/31/2020 - 1/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DRMA Dermata Therapeutics, Inc.
1.2600
-7.35%
CMND Clearmind Medicine Inc.
1.4400
-3.36%
PHIO Phio Pharmaceuticals Corp.
1.6900
-6.63%
WINT Windtree Therapeutics, Inc.
0.2689
-11.02%
TCBP TC Biopharm (Holdings) Plc
0.4050
-2.64%
PTIX Protagenic Therapeutics, Inc.
0.5482
-5.14%
ADIL Adial Pharmaceuticals, Inc.
1.0200
-4.67%
GDTC CytoMed Therapeutics Limited
2.2900
-22.64%
KLTO Klotho Neurosciences, Inc.
0.4481
-8.94%
VIRX Viracta Therapeutics, Inc.
0.1877
-11.04%